[{"address1": "4660 La Jolla Village Drive", "address2": "Suite 100", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "650 800 3717", "website": "https://www.revbiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.", "fullTimeEmployees": 9, "maxAge": 86400, "priceHint": 4, "previousClose": 2.15, "open": 2.1184, "dayLow": 2.09, "dayHigh": 2.33, "regularMarketPreviousClose": 2.15, "regularMarketOpen": 2.1184, "regularMarketDayLow": 2.09, "regularMarketDayHigh": 2.33, "beta": 0.188, "forwardPE": -0.40344167, "volume": 31377, "regularMarketVolume": 31377, "averageVolume": 50104, "averageVolume10days": 38070, "averageDailyVolume10Day": 38070, "marketCap": 3445503, "fiftyTwoWeekLow": 1.61, "fiftyTwoWeekHigh": 31.2, "fiftyDayAverage": 2.09062, "twoHundredDayAverage": 10.37006, "currency": "USD", "enterpriseValue": -11106247, "floatShares": 1624460, "sharesOutstanding": 1632940, "sharesShort": 24780, "sharesShortPriorMonth": 18541, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0152, "heldPercentInsiders": 0.00324, "heldPercentInstitutions": 0.00522, "shortRatio": 0.54, "shortPercentOfFloat": 0.0152, "impliedSharesOutstanding": 1754460, "bookValue": 5.801, "priceToBook": 0.36373037, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -8960882, "trailingEps": -48.51, "forwardEps": -5.23, "lastSplitFactor": "1:30", "lastSplitDate": 1706140800, "enterpriseToEbitda": 1.246, "52WeekChange": -0.92517734, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "REVB", "underlyingSymbol": "REVB", "shortName": "Revelation Biosciences, Inc.", "longName": "Revelation Biosciences, Inc.", "firstTradeDateEpochUtc": 1605623400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f994477e-3690-3dde-965e-6f9faa0f03d6", "messageBoardId": "finmb_696222591", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.11, "targetHighPrice": 25.0, "targetLowPrice": 12.4, "targetMeanPrice": 18.7, "targetMedianPrice": 18.7, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 14551740, "totalCashPerShare": 8.911, "ebitda": -8913907, "quickRatio": 2.783, "currentRatio": 2.797, "returnOnAssets": -0.34045, "returnOnEquity": -0.9195, "freeCashflow": -8037704, "operatingCashflow": -8549101, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]